Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

71 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Clinical and Immunological Features of Patients with Primary Antibody Deficiencies.
Azizi G, Bagheri Y, Tavakol M, Askarimoghaddam F, Porrostami K, Rafiemanesh H, Yazdani R, Kiaee F, Habibi S, Abouhamzeh K, Mohammadi H, Qorbani M, Abolhassani H, Aghamohammadi A. Azizi G, et al. Among authors: bagheri y. Endocr Metab Immune Disord Drug Targets. 2018;18(5):537-545. doi: 10.2174/1871530318666180413110216. Endocr Metab Immune Disord Drug Targets. 2018. PMID: 29651973
Diagnostic Approach to the Patients with Suspected Primary Immunodeficiency.
Tavakol M, Jamee M, Azizi G, Sadri H, Bagheri Y, Zaki-Dizaji M, Mahdavi FS, Jadidi-Niaragh F, Tajfirooz S, Kamali AN, Aghamahdi F, Noorian S, Kojidi HT, Mosavian M, Matani R, Dolatshahi E, Porrostami K, Elahimehr N, Fatemi-Abhari M, Sharifi L, Arjmand R, Haghi S, Zainaldain H, Yazdani R, Shaghaghi M, Abolhassani H, Aghamohammadi A. Tavakol M, et al. Among authors: bagheri y. Endocr Metab Immune Disord Drug Targets. 2020;20(2):157-171. doi: 10.2174/1871530319666190828125316. Endocr Metab Immune Disord Drug Targets. 2020. PMID: 31456526 Review.
The profile of IL-4, IL-5, IL-10 and GATA3 in patients with LRBA deficiency and CVID with no known monogenic disease: Association with disease severity.
Azizi G, Bagheri Y, Yazdani R, Zaki-Dizaji M, Jamee M, Jadidi-Niaragh F, Kamali AN, Abolhassani H, Aghamohammadi A. Azizi G, et al. Among authors: bagheri y. Allergol Immunopathol (Madr). 2019 Mar-Apr;47(2):172-178. doi: 10.1016/j.aller.2018.06.003. Epub 2018 Sep 5. Allergol Immunopathol (Madr). 2019. PMID: 30193889
Autoimmunity in a cohort of 471 patients with primary antibody deficiencies.
Azizi G, Tavakol M, Rafiemanesh H, Kiaee F, Yazdani R, Heydari A, Abouhamzeh K, Anvari P, Mohammadikhajehdehi S, Sharifia L, Bagheri Y, Mohammadi H, Abolhassani H, Aghamohammadi A. Azizi G, et al. Among authors: bagheri y. Expert Rev Clin Immunol. 2017 Nov;13(11):1099-1106. doi: 10.1080/1744666X.2017.1384312. Epub 2017 Oct 11. Expert Rev Clin Immunol. 2017. PMID: 29019451
Evaluation of Radiation Sensitivity in Patients with Hyper IgM Syndrome.
Fekrvand S, Mozdarani H, Delavari S, Sohani M, Nazari F, Kiaee F, Bagheri Y, Azizi G, Hassanpour G, Mozdarani S, Abolhassani H, Aghamohammadi A, Yazdani R. Fekrvand S, et al. Among authors: bagheri y. Immunol Invest. 2021 Jul;50(5):580-596. doi: 10.1080/08820139.2020.1779288. Epub 2020 Jun 25. Immunol Invest. 2021. PMID: 32584193
Anti-Inflammatory Effect of KW-2449 on Autoimmune Encephalomyelitis: An Experimental Study on Mice.
Ahmadabad HN, Abbaspour A, Panahi Y, Tahmasebi S, Hossein-Khannazer N, Afraei S, Miladi H, Goudarzvand M, Kamali AN, Bagheri Y, Yazdani R, Di Fiore MM, Azizi G. Ahmadabad HN, et al. Among authors: bagheri y. Endocr Metab Immune Disord Drug Targets. 2021;21(9):1590-1597. doi: 10.2174/1871530320666201106095808. Endocr Metab Immune Disord Drug Targets. 2021. PMID: 33155932
The fatty acid-binding protein (FABP) decreases the clinical signs and modulates immune responses in a mouse model of experimental autoimmune encephalomyelitis (EAE).
Hajizadeh M, Saboor-Yaraghi AA, Meamar AR, Khoshmirsafa M, Razmjou E, Sadeghipour A, Bagheri Y, Sadeghi F, Jalallou N, Kazemi MH, Salari AA, Falak R. Hajizadeh M, et al. Among authors: bagheri y. Int Immunopharmacol. 2021 Jul;96:107756. doi: 10.1016/j.intimp.2021.107756. Epub 2021 May 13. Int Immunopharmacol. 2021. PMID: 33993100
Difference of cardiac rehabilitation in the morning or evening on indexes of left ventricular and N-terminal pro-brain natriuretic peptide: a randomized controlled trial.
Dehghani M, Cheragi M, Delfan B, Dehghani M, Shakarami A, Bagheri Y, Namdari P, Namdari M. Dehghani M, et al. Among authors: bagheri y. Ann Med Surg (Lond). 2023 Jun 9;85(7):3482-3490. doi: 10.1097/MS9.0000000000000580. eCollection 2023 Jul. Ann Med Surg (Lond). 2023. PMID: 37427217 Free PMC article.
B cells and T cells abnormalities in patients with selective IgA deficiency.
Bagheri Y, Moeini Shad T, Namazi S, Tofighi Zavareh F, Azizi G, Salami F, Sadani S, Hosseini A, Saeidi M, Pashangzadeh S, Delavari S, Mirminachi B, Rezaei N, Abolhassani H, Aghamohammadi A, Yazdani R. Bagheri Y, et al. Allergy Asthma Clin Immunol. 2023 Mar 20;19(1):23. doi: 10.1186/s13223-023-00775-6. Allergy Asthma Clin Immunol. 2023. PMID: 36941677 Free PMC article.
Microbiota and glomerulonephritis: An immunological point of view.
Ardalan M, Ahmadian E, Hosseiniyan Khatibi SM, Rahbar Saadat Y, Bastami M, Bagheri Y, Zununi Vahed F, Shoja MM, Zununi Vahed S. Ardalan M, et al. Among authors: bagheri y. Am J Med Sci. 2022 Dec;364(6):695-705. doi: 10.1016/j.amjms.2022.05.025. Epub 2022 Jul 20. Am J Med Sci. 2022. PMID: 35870511 Review.
Recent clinical findings on the role of kinase inhibitors in COVID-19 management.
Malekinejad Z, Baghbanzadeh A, Nakhlband A, Baradaran B, Jafari S, Bagheri Y, Raei F, Montazersaheb S, Farahzadi R. Malekinejad Z, et al. Among authors: bagheri y. Life Sci. 2022 Oct 1;306:120809. doi: 10.1016/j.lfs.2022.120809. Epub 2022 Jul 13. Life Sci. 2022. PMID: 35841979 Free PMC article. Review.
Hepatoprotective effects of sericin on aging-induced liver damage in mice.
Bagheri Y, Sadigh-Eteghad S, Fathi E, Mahmoudi J, Abdollahpour A, Namini NJ, Malekinejad Z, Mokhtari K, Barati A, Montazersaheb S. Bagheri Y, et al. Naunyn Schmiedebergs Arch Pharmacol. 2021 Dec;394(12):2441-2450. doi: 10.1007/s00210-021-02160-9. Epub 2021 Oct 4. Naunyn Schmiedebergs Arch Pharmacol. 2021. PMID: 34605941
Renoprotective effects of prazosin on ischemia-reperfusion injury in rats.
Rahimi MM, Bagheri A, Bagheri Y, Fathi E, Bagheri S, Nia AV, Jafari S, Montazersaheb S. Rahimi MM, et al. Among authors: bagheri y, bagheri s, bagheri a. Hum Exp Toxicol. 2021 Aug;40(8):1263-1273. doi: 10.1177/0960327121993224. Epub 2021 Feb 9. Hum Exp Toxicol. 2021. PMID: 33559503
A Genetically Encoded RNA Photosensitizer for Targeted Cell Regulation.
Ren K, Keshri P, Wu R, Sun Z, Yu Q, Tian Q, Zhao B, Bagheri Y, Xie Y, You M. Ren K, et al. Among authors: bagheri y. Angew Chem Int Ed Engl. 2020 Dec 1;59(49):21986-21990. doi: 10.1002/anie.202010106. Epub 2020 Oct 7. Angew Chem Int Ed Engl. 2020. PMID: 32797667 Free PMC article.